| Product Code: ETC8892325 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Pneumococcal Vaccine Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Portugal Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Portugal Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Portugal Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Portugal Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Portugal Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Portugal Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Portugal Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased awareness about the importance of vaccination in preventing pneumococcal diseases |
4.2.2 Government initiatives and programs to promote vaccination coverage |
4.2.3 Growing elderly population and increasing prevalence of chronic diseases that make individuals more susceptible to pneumococcal infections |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines leading to affordability issues for some segments of the population |
4.3.2 Lack of awareness or misconceptions about the safety and efficacy of pneumococcal vaccines |
4.3.3 Limited access to healthcare services in remote or underserved areas impacting vaccine distribution and administration |
5 Portugal Pneumococcal Vaccine Market Trends |
6 Portugal Pneumococcal Vaccine Market, By Types |
6.1 Portugal Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Portugal Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Portugal Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Portugal Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Portugal Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Portugal Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Portugal Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Portugal Pneumococcal Vaccine Market Export to Major Countries |
7.2 Portugal Pneumococcal Vaccine Market Imports from Major Countries |
8 Portugal Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate among target populations (e.g., children, elderly) |
8.2 Number of pneumococcal vaccine doses administered annually |
8.3 Percentage of healthcare facilities offering pneumococcal vaccination services |
8.4 Rate of adverse events following pneumococcal vaccination |
9 Portugal Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Portugal Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Portugal Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Portugal Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Portugal Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Portugal Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Portugal Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Portugal Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Portugal Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here